Comment Central
VerifiedMagazine
Actions
Media Outlet details
| Scope | International, Trade/B2B |
|---|---|
| Language | English |
| Country | United Kingdom |
|
Similarweb UVM |
Request pricing |
|
Comscore UVM |
Request pricing |
Recent Articles
Search ArticlesPulling the curtain back on A&E hospital services
Like age, clinical complaint also factors into how long people must wait. Complaints about airways/breathing, gastrointestinal, or neurological issues – problems that are internal, possibly more complex, and need longer to resolve – constitute the biggest segment of those who wait over 12 hours. The presumption may plausibly be that the most vulnerable patients are likely to be assigned a bed sooner, but evidence is stacked the other way round.
The UK-US Medicines Deal is a Hidden Cost of Brexit
The government’s post-Brexit strategy was to preserve competitiveness through regulatory agility. Central to that effort was reform of the MHRA. The medicines authorisation framework was modernised to attract innovation and speed up approvals; clinical trials underwent what was billed as the “biggest overhaul in trial regulation in 20 years.” The newly “sovereign” MHRA was meant to become a world-leading regulator that would help drive the UK’s transformation into a life-sciences "superpower".
Beyond the Supplier-Client Dynamic: Strategic Autonomy and the Future of U.S.–Israel Ties
Crucially, this change shouldn't be seen as a sign of detachment or retreat into isolation; rather, it's a sensible response to the new realities of our world. Right now, governments in the West are scrambling to increase ammunition production, but their defense industries are facing tough challenges. Factors like high global demand, low inventory levels, and intense political discussions in Washington are all putting pressure on these systems.
Aid May Start Rebuilding Gaza, But Only Markets Can Finish It
Gaza's reconstruction is back in the news after Pope Leo XIV recently appealed to the world to help begin the post-war reconstruction of the area. A secure and prosperous Gaza is beneficial to Gazans, Israel, and stability across the Middle East, but we must think more deeply about how we get there. There is a pattern to the end of wars. A donor conference is convened, a headline aid figure is debated, and an international authority is selected to spend the aid. Gaza is the latest example.
The Hidden Epidemic: What We Don't Know About Lyme Disease in the UK
The UK Health Security Agency’s (UKHSA) reported rise in Lyme disease cases makes for eye-catching news at a time when climate-related health impacts are being felt intensely. There is strong evidence that climate affects the spatial and temporal patterns of risk. Warmer conditions can support the survival and increased abundance of ticks that can transmit Lyme disease.
AI & US: Too Big Not to Fail?
AI towers over us. It is not just an economic force. It is social and political too. The public debate has two endings. In the good one, AI makes us so productive that work becomes optional and prosperity spreads. In the bad one, it destroys jobs, concentrates wealth, and hands more power to those who own the systems. This essay asks how we get to either future. The answer is uncomfortable. US AI may be too big not to fail. That does not mean AI will fade.
Is Britain’s dithering on defence damaging our alliances?
Anyone hoping a renewed Labour government would get serious on defence have been treated to the most unserious of political summers in recent memory. Andy Burnham’s more hawkish rhetoric on NATO, Ukraine, Trident and the defence industrial base has failed to be matched by the hard spending decisions required to improve the parlous state of Britain’s armed forces.
Financial Toxicity of Cancer: From Hope to Coffin
She came from the remote hills of Jumla with one hope: to live. The journey to Kathmandu took days, filled with faith that Nepal's largest government hospital would offer her a second chance at life. She carried no wealth, no influential connections, only a health insurance card, a few clothes, and the unwavering support of her family. Like thousands of cancer patients from rural Nepal, she believed that reaching the hospital was the hardest part of the battle. She was wrong.
NHS Innovation and Economic Growth
It’s commonly said that the NHS has an innovation problem; it struggles to adopt novel technologies, is poor at implementing established innovation, and fails to scale what works. I’d argue that this is incorrect; there’s lots of innovation in the NHS, as demonstrated by the numerous pilots. Innovative technology is often found across large parts of the NHS, for example, virtual wards, blood glucose monitoring, patient messaging platforms and online consultations.
Our exam system puts too much unnecessary pressure on young people, and it must change.
Since the mid-2010s, secondary school qualifications have almost entirely been assessed by end of two-year course examinations. GCSE students sit an average of 31.5 hours of exams in a single month - that’s more than most students in comparable education systems around the world. At YoungMinds we know that when a young person’s grades depend on such a condensed period of high-stakes exams, the pressure can become overwhelming.